201 related articles for article (PubMed ID: 29534537)
1. Discovery of Oxime Ethers as Hepatitis B Virus (HBV) Inhibitors by Docking, Screening and In Vitro Investigation.
Tan J; Zhou M; Cui X; Wei Z; Wei W
Molecules; 2018 Mar; 23(3):. PubMed ID: 29534537
[TBL] [Abstract][Full Text] [Related]
2. [Design, virtual screening, synthesis and anti-hepatitis B virus of oxime derivatives].
Cui XH; Tan J; Zhou M; Wei WX; Liu X; Wang LS
Yao Xue Xue Bao; 2016 Oct; 51(10):1578-83. PubMed ID: 29932603
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
Liu S; Wei W; Li Y; Liu X; Cao X; Lei K; Zhou M
Eur J Med Chem; 2015 May; 95():473-82. PubMed ID: 25847765
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis and Bioactive Evaluation of Oxime Derivatives of Dehydrocholic Acid as Anti-Hepatitis B Virus Agents.
Wei Z; Tan J; Cui X; Zhou M; Huang Y; Zang N; Chen Z; Wei W
Molecules; 2020 Jul; 25(15):. PubMed ID: 32722086
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Bioactive Screen In Vitro of Cyclohexyl (
Cui X; Zhou M; Tan J; Wei Z; Wei W; Luo P; Lin C
Molecules; 2019 May; 24(11):. PubMed ID: 31151219
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives.
Liu S; Li Y; Wei W; Wang K; Wang L; Wang J
Chem Biol Interact; 2016 May; 251():1-9. PubMed ID: 26980103
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents.
Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Guo RH; Zhang XM; Chen JJ
Bioorg Med Chem; 2012 May; 20(9):2877-88. PubMed ID: 22472044
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents.
Guo RH; Zhang Q; Ma YB; Luo J; Geng CA; Wang LJ; Zhang XM; Zhou J; Jiang ZY; Chen JJ
Eur J Med Chem; 2011 Jan; 46(1):307-19. PubMed ID: 21145140
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of celastrol derivatives as potential non-nucleoside hepatitis B virus inhibitors.
Zhang H; Lu G
Chem Biol Drug Des; 2020 Dec; 96(6):1380-1386. PubMed ID: 32573976
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors.
Jia H; Bai F; Liu N; Liang X; Zhan P; Ma C; Jiang X; Liu X
Eur J Med Chem; 2016 Nov; 123():202-210. PubMed ID: 27484509
[TBL] [Abstract][Full Text] [Related]
11. Anti-hepatitis B virus activities of friedelolactones from Viola diffusa Ging.
Dai JJ; Tao HM; Min QX; Zhu QH
Phytomedicine; 2015 Jul; 22(7-8):724-9. PubMed ID: 26141758
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of caudatin analogs as potent hepatitis B virus inhibitors.
Wang LJ; Chen H; Ma YB; Huang XY; Geng CA; Zhang XM; Chen JJ
Med Chem; 2015; 11(2):165-79. PubMed ID: 25181984
[TBL] [Abstract][Full Text] [Related]
13. Anti-HBV agents. Part 2: synthesis and in vitro anti-hepatitis B virus activities of alisol A derivatives.
Zhang Q; Jiang ZY; Luo J; Liu JF; Ma YB; Guo RH; Zhang XM; Zhou J; Chen JJ
Bioorg Med Chem Lett; 2009 Apr; 19(8):2148-53. PubMed ID: 19289281
[TBL] [Abstract][Full Text] [Related]
14. Anti-hepatitis B virus active constituents from Swertia chirayita.
Zhou NJ; Geng CA; Huang XY; Ma YB; Zhang XM; Wang JL; Chen JJ
Fitoterapia; 2015 Jan; 100():27-34. PubMed ID: 25447162
[TBL] [Abstract][Full Text] [Related]
15. Anti-hepatitis B virus activity of wogonin in vitro and in vivo.
Guo Q; Zhao L; You Q; Yang Y; Gu H; Song G; Lu N; Xin J
Antiviral Res; 2007 Apr; 74(1):16-24. PubMed ID: 17280723
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo anti-hepatitis B virus activities of the lignan niranthin isolated from Phyllanthus niruri L.
Liu S; Wei W; Shi K; Cao X; Zhou M; Liu Z
J Ethnopharmacol; 2014 Sep; 155(2):1061-7. PubMed ID: 25009077
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro.
Boulon R; Blanchet M; Lemasson M; Vaillant A; Labonté P
Antiviral Res; 2020 Nov; 183():104853. PubMed ID: 32585322
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus.
Pang YJ; Tan XJ; Li DM; Zheng ZH; Lei RX; Peng XM
Liver Int; 2013 Sep; 33(8):1230-8. PubMed ID: 23617302
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives.
Huang TJ; Yang CL; Kuo YC; Chang YC; Yang LM; Chou BH; Lin SJ
Bioorg Med Chem; 2015 Feb; 23(4):720-8. PubMed ID: 25600408
[TBL] [Abstract][Full Text] [Related]
20. Anti-HBV Activities of Three Compounds Extracted and Purified from Herpetospermum Seeds.
Gong PY; Yuan ZX; Gu J; Tan R; Li JC; Ren Y; Hu S
Molecules; 2016 Dec; 22(1):. PubMed ID: 28035986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
